Similar articles for PMID: 11256231

Year	Number of Results
1987	1
1988	1
1992	1
1993	1
1995	2
1997	2
1998	5
1999	8
2000	11
2001	5
2002	18
2003	4
2004	9
2005	6
2006	6
2007	5
2008	4
2009	8
2010	6
2011	12
2012	16
2013	13
2014	12
2015	1
2016	8
2017	9
2018	8
2019	23
2020	34
2021	36
2022	32
2023	12
2024	0

1

Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrylcholinesterase in vitro.

Ogura H, Kosasa T, Kuriya Y, Yamanishi Y. Ogura H, et al. Methods Find Exp Clin Pharmacol. 2000 Oct;22(8):609-13. doi: 10.1358/mf.2000.22.8.701373. Methods Find Exp Clin Pharmacol. 2000. PMID: 11256231 Free article.

2

Potencies and selectivities of inhibitors of acetylcholinesterase and its molecular forms in normal and Alzheimer's disease brain.

Rakonczay Z. Rakonczay Z. Acta Biol Hung. 2003;54(2):183-9. doi: 10.1556/ABiol.54.2003.2.7. Acta Biol Hung. 2003. PMID: 14535624

3

Inhibitory effect of orally administered donepezil hydrochloride (E2020), a novel treatment for Alzheimer's disease, on cholinesterase activity in rats.

Kosasa T, Kuriya Y, Matsui K, Yamanishi Y. Kosasa T, et al. Eur J Pharmacol. 2000 Feb 18;389(2-3):173-9. doi: 10.1016/s0014-2999(99)00876-6. Eur J Pharmacol. 2000. PMID: 10688981

4

Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.

Zhao Q, Tang XC. Zhao Q, et al. Eur J Pharmacol. 2002 Nov 29;455(2-3):101-7. doi: 10.1016/s0014-2999(02)02589-x. Eur J Pharmacol. 2002. PMID: 12445575

5

Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats.

Kosasa T, Kuriya Y, Matsui K, Yamanishi Y. Kosasa T, et al. Eur J Pharmacol. 1999 Sep 10;380(2-3):101-7. doi: 10.1016/s0014-2999(99)00545-2. Eur J Pharmacol. 1999. PMID: 10513568

6

Different cholinesterase inhibitor effects on CSF cholinesterases in Alzheimer patients.

Nordberg A, Darreh-Shori T, Peskind E, Soininen H, Mousavi M, Eagle G, Lane R. Nordberg A, et al. Curr Alzheimer Res. 2009 Feb;6(1):4-14. doi: 10.2174/156720509787313961. Curr Alzheimer Res. 2009. PMID: 19199870 Free PMC article. Clinical Trial.

7

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors.

Jann MW, Shirley KL, Small GW. Jann MW, et al. Clin Pharmacokinet. 2002;41(10):719-39. doi: 10.2165/00003088-200241100-00003. Clin Pharmacokinet. 2002. PMID: 12162759 Review.

8

Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.

Kaasinen V, Någren K, Järvenpää T, Roivainen A, Yu M, Oikonen V, Kurki T, Rinne JO. Kaasinen V, et al. J Clin Psychopharmacol. 2002 Dec;22(6):615-20. doi: 10.1097/00004714-200212000-00012. J Clin Psychopharmacol. 2002. PMID: 12454562 Clinical Trial.

9

Pharmacology of selective acetylcholinesterase inhibitors: implications for use in Alzheimer's disease.

Liston DR, Nielsen JA, Villalobos A, Chapin D, Jones SB, Hubbard ST, Shalaby IA, Ramirez A, Nason D, White WF. Liston DR, et al. Eur J Pharmacol. 2004 Feb 13;486(1):9-17. doi: 10.1016/j.ejphar.2003.11.080. Eur J Pharmacol. 2004. PMID: 14751402

10

Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina.

Amici S, Lanari A, Romani R, Antognelli C, Gallai V, Parnetti L. Amici S, et al. Mech Ageing Dev. 2001 Nov;122(16):2057-62. doi: 10.1016/s0047-6374(01)00314-1. Mech Ageing Dev. 2001. PMID: 11589922

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

294 results

Results by year